September 1st
August 25th
July 27th
July 8th
May 2nd
April 16th
March 2nd
October 26th
August 3rd
May 18th
February 22nd
June 6th
May 25th
No video for Dyspnea is available at this time.
United Therapeutics Dips In Pre-Market On Disappointing Hypertension ... - RTT News
(RTTNews) - United Therapeutics (UTHR: News ) slid in pre-market trading, after stating that its FREEDOM-C trial of oral treprostinil in pulmonary arterial hypertension failed to meet its primary endpoint. The stock was down $27.02 just before 8:50 ...
Recurrent Aspiration Pneumonia - New England Journal of Medicine
An 84-year-old man with coronary artery disease, atrial fibrillation, chronic obstructive pulmonary disease, and congestive heart failure was admitted to the hospital because of a decrease in mental status. He was found to have profound ...
FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial ... - PR Newswire
SILVER SPRING, Md., Nov. 17 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the results of the FREEDOM-C trial of oral treprostinil, a sustained-release formulation of treprostinil, in pulmonary arterial ...
New Data Will Be Presented at ASH on Velcade (Bortezomib) for ... - Phramalive.com
CAMBRIDGE, Mass., November 18, 2008 /PRNewswire/ -- Millennium: The Takeda Oncology Company today announced that 120 data presentations concerning VELCADE research will be featured at the 50th American Society of Hematology (ASH) Annual Meeting in ...
New Data Will Be Presented at ASH on VELCADE(R) (Bortezomib) for ... - PR Newswire
CAMBRIDGE, Mass., Nov. 18 /PRNewswire/ -- Millennium: The Takeda Oncology Company today announced that 120 data presentations concerning VELCADE research will be featured at the 50th American Society of Hematology (ASH) Annual Meeting in San ...
Do you prefer to listen to your dyspnea gossip? Check out Podzy Podcast Directory > Dyspnea.
Looking for dyspnea related products, then look no further. Try our new Dyspnea Shop.